Soterya, Inc. — SEC Form D Filing

Soterya, Inc. filed an SEC Form D on October 13, 2026, reporting $850K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
October 13, 2026
Amount reported
$850K
Round stage
Seed
Industry
Medical Devices
Website
https://soteryabio.com/

What the company does

Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Patients and individuals, particularly those with mobility limitations, face unmet needs for in-bed care, including risks from immobility like pressure injuries and SUDEP, lack of comfort and independence, and challenges for caregivers. Common issues like snoring, back pain, and sleep apnea are also often exacerbated by sustained or poor sleep positions.

Solution

Soterya develops Korus, an autonomous repositioning bed that uses Physical-AI to sense the body and automatically adjust a person's position. This technology provides mobility support, protects against issues like SUDEP and pressure injuries, and can improve comfort and address positional snoring, back pain, and sleep apnea.

Why now

There's an increasing demand for independent living solutions for aging populations and a growing awareness of caregiver burnout. Advancements in AI, sensor technology, and automation make autonomous care systems feasible and necessary to address these challenges.

Verdict

Investors backed Soterya because the articulated problem of immobility and pressure injuries presented a clear cost-saving opportunity for institutions, not because the consumer wellness pitch showed immediate scalability. The implicit bet was on a defined regulatory pathway and clinical validation within the medical device space, assuming the 'Physical-AI' aspect was more than just marketing jargon. Upside was limited by the capital intensity of medical device development and the long sales cycles inherent in institutional adoption, rather than by a lack of perceived market size.

Source: SEC EDGAR Form D filing